Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ana Moyano"'
Autor:
Ana Moyano, Oscar Blanch-Lombarte, Laura Tarancon-Diez, Nuria Pedreño-Lopez, Miguel Arenas, Tamara Alvaro, Concepción Casado, Isabel Olivares, Mar Vera, Carmen Rodriguez, Jorge del Romero, Cecilio López-Galíndez, Ezequiel Ruiz-Mateos, Julia G. Prado, María Pernas
Publikováno v:
Retrovirology, Vol 19, Iss 1, Pp 1-14 (2022)
Abstract Background Long-Term Non-Progressors (LTNPs) are untreated Human Immunodeficiency virus type 1 (HIV-1) infected individuals able to control disease progression for prolonged periods. However, the LTNPs status is temporary, as viral load incr
Externí odkaz:
https://doaj.org/article/9781fb5c03ed4e0cb8b67f8ba4137e88
Autor:
Ana Moyano, Bongiwe Ndlovu, Msizi Mbele, Kewreshini Naidoo, Nasreen Khan, Jaclyn K Mann, Thumbi Ndung'u
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286507 (2023)
Previous work suggests that HIV controllers with protective human leukocyte antigen class I alleles (VC+) possess a high breadth of Gag-specific CD8+ T cell responses, while controllers without protective alleles (VC-) have a different unknown mechan
Externí odkaz:
https://doaj.org/article/1036a0e035574194998ef71454b4da01
Publikováno v:
PLoS Computational Biology, Vol 16, Iss 2, p e1007482 (2020)
HIV infection can be cleared with antiretroviral drugs if they are administered before exposure, where exposure occurs at low viral doses which infect one or few cells. However, infection clearance does not happen once infection is established, and t
Externí odkaz:
https://doaj.org/article/3456b83a55ee458db943cc5e9aa3e0c8
Autor:
Mesa Carlos Latorre, de Cos Guillermo Velasco, Bonet Aurelia Villar, Martinez Ana Moyano, Zapata Maldonado Gabriela Alexandra, Monterrubio Maialen Ormazabal, Lavin Gomez Bernardo Alio, Garcia-Unzueta Maria Teresa
Publikováno v:
Endocrine Abstracts.
Autor:
de Cos Guillermo Velasco, Mesa Carlos Latorre, Garcia-Unzueta Maria Teresa, Luis Vazquez, Monterrubio Maialen Ormazabal, Ruiz Armando Guerra, Martinez Ana Moyano, Zapata Maldonado Gabriela Alexandra, Bonet Aurelia Villar
Publikováno v:
Endocrine Abstracts.
Autor:
Marta Iturralde Ros, Isabel Sánchez-Molina Acosta, Guillermo Velasco de Cos, Ainhoa Maiztegi Azpitarte, Ana Moyano Martinez
Publikováno v:
Advances in Laboratory Medicine, Vol 2, Iss 4, Pp 579-582 (2021)
Resumen Objectivos El uso de heparina de bajo peso molecular está muy extendido en la práctica clínica. En muy raras ocasiones, algunos pacientes desarrollan hepatitis pocos días después de haber iniciado el tratamiento, y la inmediata suspensi
Autor:
Isabel Sánchez-Molina Acosta, Ana Moyano Martinez, Guillermo Velasco de Cos, Ainhoa Maiztegi Azpitarte, Marta Iturralde Ros
Publikováno v:
Advances in Laboratory Medicine, Vol 2, Iss 4, Pp 575-578 (2021)
Objectives Treatment with low-molecular-weight heparins is very common in clinical practice. Exceptionally, some patients develop hepatitis within a few days of starting treatment, and rapid discontinuation of the drug is decisive to avoid chronifica
Publikováno v:
Aids Reviews. 24
HIV-1 infection usually progresses to AIDS within 10 years in antiretroviral therapy untreated individuals, but there is a group of infected individuals, known as controllers, who maintain low plasma HIV-1 RNA levels and normal CD4+ T-cell counts for
Autor:
Ana Moyano, Oscar Blanch-Lombarte, Laura Tarancon-Diez, Nuria Pedreño-Lopez, Miguel Arenas, Tamara Alvaro, Concepción Casado, Isabel Olivares, Mar Vera, Carmen Rodriguez, Jorge del Romero, Cecilio López-Galíndez, Ezequiel Ruiz-Mateos, Julia G. Prado, María Pernas
Publikováno v:
Retrovirology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
[Background] Long-Term Non-Progressors (LTNPs) are untreated Human Immunodeficiency virus type 1 (HIV-1) infected individuals able to control disease progression for prolonged periods. However, the LTNPs status is temporary, as viral load increases f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3084c8f1e1aefa738a6c2c82caf76e39
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2540
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2540
Publikováno v:
PLoS Computational Biology
PLoS Computational Biology, Vol 16, Iss 2, p e1007482 (2020)
Moyano, A, Lustig, G, Rodel, H E, Antal, T & Sigal, A 2020, ' Interference with HIV infection of the first cell is essential for viral clearance at sub-optimal levels of drug inhibition ', PLoS Computational Biology . https://doi.org//10.1371/journal.pcbi.1007482
PLoS Computational Biology, Vol 16, Iss 2, p e1007482 (2020)
Moyano, A, Lustig, G, Rodel, H E, Antal, T & Sigal, A 2020, ' Interference with HIV infection of the first cell is essential for viral clearance at sub-optimal levels of drug inhibition ', PLoS Computational Biology . https://doi.org//10.1371/journal.pcbi.1007482
HIV infection can be cleared with antiretroviral drugs if they are administered before exposure, where exposure occurs at low viral doses which infect one or few cells. However, infection clearance does not happen once infection is established, and t